October 22, 2021

Dr. Johns interviewed by Healio

Regenstrief Research Scientist Shelley Johns, PysD, outlined how acceptance and commitment therapy can be beneficial to breast cancer survivors who are dealing with fear of cancer recurrence.

Regenstrief Research Scientist Shelley Johns, PysD, outlined how acceptance and commitment therapy can be beneficial to breast cancer survivors who are dealing with fear of cancer recurrence.

READ THE HEALIO ARTICLE
The Latest
Dr. Grout: UNAFIED AI model helps predict early heart disorder risk, helping clinicians
Video

Dr. Grout: UNAFIED AI model helps predict early heart disorder risk, helping clinicians

Assessing pain, anxiety and other symptoms of nursing home residents unable to speak for themselves
News

Assessing pain, anxiety and other symptoms of nursing home residents unable to speak for themselves

LOINC® spring stakeholder webinar to highlight latest updates and strategic initiatives
News

LOINC® spring stakeholder webinar to highlight latest updates and strategic initiatives

AI model predicting two-year risk of common heart disorder can easily be integrated into healthcare workflow
News

AI model predicting two-year risk of common heart disorder can easily be integrated into healthcare workflow

Predicting Alzheimer’s disease subtypes and understanding their molecular characteristics in living patients with transcriptomic trajectory profiling
Influence

Predicting Alzheimer’s disease subtypes and understanding their molecular characteristics in living patients with transcriptomic trajectory profiling

Local healthcare leader joins Regenstrief Institute Board of Directors
News

Local healthcare leader joins Regenstrief Institute Board of Directors